[HTML][HTML] Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre …
JA Bridgewater, SA Pugh, T Maishman… - The lancet …, 2020 - thelancet.com
Background The interim analysis of the multicentre New EPOC trial in patients with
resectable colorectal liver metastasis showed a significant reduction in progression-free …
resectable colorectal liver metastasis showed a significant reduction in progression-free …
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised …
JA Bridgewater, SA Pugh, T Maishman, Z Eminton… - 2020 - christie.openrepository.com
BACKGROUND: The interim analysis of the multicentre New EPOC trial in patients with
resectable colorectal liver metastasis showed a significant reduction in progression-free …
resectable colorectal liver metastasis showed a significant reduction in progression-free …
[PDF][PDF] Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre …
JA Bridgewater, SA Pugh, T Maishman, Z Eminton… - 2020 - academia.edu
Background The interim analysis of the multicentre New EPOC trial in patients with
resectable colorectal liver metastasis showed a significant reduction in progression-free …
resectable colorectal liver metastasis showed a significant reduction in progression-free …
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised …
JA Bridgewater, SA Pugh, T Maishman… - The Lancet …, 2020 - discovery.ucl.ac.uk
BACKGROUND: The interim analysis of the multicentre New EPOC trial in patients with
resectable colorectal liver metastasis showed a significant reduction in progression-free …
resectable colorectal liver metastasis showed a significant reduction in progression-free …
[HTML][HTML] Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre …
JA Bridgewater, SA Pugh, T Maishman, Z Eminton… - The Lancet …, 2020 - Elsevier
Background The interim analysis of the multicentre New EPOC trial in patients with
resectable colorectal liver metastasis showed a significant reduction in progression-free …
resectable colorectal liver metastasis showed a significant reduction in progression-free …
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: Long-term results of the New EPOC randomised clinical trial
J Bridgewater, S Pugh, T Maishman… - The Lancet …, 2020 - research.ed.ac.uk
Background The interim analysis of the multicentre New EPOC trial in patients with
resectable colorectal liver metastasis showed a significant reduction in progression-free …
resectable colorectal liver metastasis showed a significant reduction in progression-free …
[PDF][PDF] Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre …
JA Bridgewater, SA Pugh, T Maishman, Z Eminton… - Lancet Oncol, 2020 - pure.ed.ac.uk
Background The interim analysis of the multicentre New EPOC trial in patients with
resectable colorectal liver metastasis showed a significant reduction in progression-free …
resectable colorectal liver metastasis showed a significant reduction in progression-free …
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): Long-term results of a multicentre, randomised …
JA Bridgewater, SA Pugh, T Maishman, Z Eminton… - Lancet …, 2020 - ora.ox.ac.uk
Background: The interim analysis of the multicentre New EPOC trial in patients with
resectable colorectal liver metastasis showed a significant reduction in progression-free …
resectable colorectal liver metastasis showed a significant reduction in progression-free …
[引用][C] Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre …
JA Bridgewater, SA Pugh, T Maishman, Z Eminton… - The Lancet …, 2020 - cir.nii.ac.jp
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver
metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial …
metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial …
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised …
JA Bridgewater, SA Pugh, T Maishman… - Lancet …, 2020 - eprints.bournemouth.ac.uk
BACKGROUND: The interim analysis of the multicentre New EPOC trial in patients with
resectable colorectal liver metastasis showed a significant reduction in progression-free …
resectable colorectal liver metastasis showed a significant reduction in progression-free …